sub field
BiotechLongevity
stage
Startup
About
Sourav Sinha is the Founding General Partner & Head of Strategy at Longevity Vision Fund, a New York-based VC dedicated to aging and longevity biotech founded in 2019. He holds an A.B. in Molecular Biology and Biochemistry from Dartmouth College, previously led regenerative medicine initiatives at Celularity (a Celgene spinout), and co-founded Oncolinx, an antibody-drug conjugate company targeting cancer. He is a 2023 Atlantic Council Millennium Fellow and a World Economic Forum Global Shaper.
Areas of interest
longevityaginghealthspanbiotechregenerative medicineoncologyantibody-drug conjugatesAI in healthcarelife sciencesdeep tech